TBP — Tetra Bio Pharma Share News
0.000.00%
Last trade - 00:00HealthcareSpeculativeMicro Cap
Brief: Tetra Bio-Pharma Confirms Agreements With Multiple Suppliers
Brief: Tetra Bio Pharma Says Recent News Regarding Aphria Does Not Affect Co In Any Way
Brief: Tetra Bio-Pharma Bolsters Intellectual Property Position And Product Pipeline
Brief: Tetra Bio-Pharma Enters Into Binding Proposal With Quantum Pharma Inc.
Brief: Tetra Bio-Pharma Enters Into Non-Binding Proposal To Acquire Panag Pharma
Brief: Tetra Bio Pharma Obtains Health Canada Approval To Conduct A Phase 1 Pharmacokinetic & Safety Study Using Vaporized Version Of PPP001
Brief: Tetra Bio-Pharma Appoints Richard Giguère CEO Of Tetra Natural Health
Brief: Tetra Bio-Pharma’S Ppp002 On Track After Type C Meeting With FDA
Brief: Tetra Bio-Pharma Announces PPP002 Program Update Following Type B Meeting With U.S. FDA
Development In Treating Fibromyalgia
Brief: Health Canada Reclassifies Tetra Bio-Pharma’S Inhalation Device Making It Eligible For Reimbursement
Brief: Tetra Bio-Pharma Accelerates Its European Drug Registration Activities
Brief: Tetra Bio Pharma Submits Multiple Applications For Orphan Drug Designation For Cannabinoids To U.S. FDA
Brief: Health Canada Approves Tetra Bio Pharma's Clinical Trial Protocol For Its Drug As An Alternative To Fentanyl
Brief: Tetra Bio-Pharma Confirms Meetings With FDA
Brief: Tetra Bio-Pharma Inc. Provides Corporate Update Ahead Of Its Annual General Meeting
Brief: Tetra Bio-Pharma Inc Strengthens Senior Management Team
Brief: Tetra Natural Health Signs Supply Agreement With Namaste Technologies For Medicinal Cannabis Product
Brief: Tetra BioPharma Signs Second Commercialization Deal With Azevedos Industria Farmaceutica